food and drug administration moderna - Search News

News

Moderna Stock Climbs

Medical Xpress · 8h

Moderna's new lower-dose COVID-19 vaccine approved by FDA

The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.

FDA Approves Moderna’s Next-Generation COVID-19 Vaccine mNexspike

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that puts them at high risk.

What you need to know about Moderna’s new COVID vaccine, just approved by the FDA

Moderna, over the weekend, announced that the U.S. Food and Drug Administration had approved its second-generation COVID vaccine, but only for specific populations: all adults 65 and over and those between 12 and 64 with at least one underlying risk factor as defined by the Centers for Disease Control and Prevention.

1don MSN

Moderna agrees to true placebo-controlled trial of new COVID vaccine, Kennedy says

U.S. Health and Human Services Secretary Robert F. Kennedy Jr. said on Tuesday that Moderna has agreed to a true ...

4don MSN

FDA approves Moderna’s new lower-dose COVID-19 vaccine

The Food and Drug administration has approved a new COVID-19 vaccine made by Moderna but with limits on who can use it.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results